Expert Review of Anti-Infective Therapy

Treatment of septic shock and use of drotrecogin alfa (activated) in children
pp. 769-772(4)
Author: Marraro, Giuseppe A

News in brief
pp. 773-775(3)

Ceftobiprole: a new cephalosporin for the treatment of skin and skin structure infections
pp. 777-791(15)
Authors: Schirmer, Patricia L; Deresinski, Stanley C

Pylera^® for the eradication of Helicobacter pylori infection
pp. 793-799(7)
Authors: Saleem, Aamir; Qasim, Asghar; O'Connor, Humphrey J; O'Morain, Colm A

The CASTLE study: atazanavir/r versus lopinavir/r in antiretroviral-naive patients
pp. 801-805(5)
Author: Chetchotisakd, Ploenchan

Host cholesterol and inflammation as common key regulators of toxoplasmosis and artherosclerosis development
pp. 807-819(13)
Authors: Portugal, Luciane R; Fernandes, Luciana R; Alvarez-Leite, Jacqueline I

Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae
pp. 821-834(14)
Authors: Tapsall, John W; Ndowa, Francis; Lewis, David A; Unemo, Magnus

Novel Helicobacter pylori therapeutic targets: the unusual suspects
pp. 835-867(33)
Authors: Duckworth, Megan J; Okoli, Arinze S; Mendz, George L

Management of bacterial infections in children with asthma
pp. 869-877(9)
Author: Korppi, Matti

Orf: an update on current research and future perspectives
pp. 879-893(15)
Authors: Hosamani, Madhusudan; Scagliarini, Alessandra; Bhanuprakash, Veerakyathappa; McInnes, Colin J; Singh, Raj Kumar

Acknowledgements
pp. 903-903(1)

Acknowledgements
pp. 903-903(1)